南予医学雑誌 第13巻 第1号
13/84

藤山:肝移植の現状南予医誌 Vol.13 No. 1 2012-11-汁性肝硬変の1例. 臨牀と研究 2010; 87(9): 1300-1301.8) Umeda N and Kamath PS: Hepatopul-monary syndrome and portopulmo-nary hypertension. Hepatol Res 2009; 39(10): 1020-1022.9) Ishigami M, Honda T, Okumura A, et al.: Use of the Model for End-Stage Liver Disease (MELD) score to pre-dict 1-year survival of Japanese pa-tients with cirrhosis and to determine who will benefit from living donor liver transplantation. J Gastroenterol 2008; 43(5): 363-368.10) 内木隆文, 森脇久隆, 持田智, 他:【急性肝不全における内科的治療と肝移植の進歩】劇症肝炎における新たな肝移植ガイドライン作成の試み. 日本腹部救急医学会雑誌 2009; 29(4): 617-622.11) Iwasaki M, Takada Y, Hayashi M, et al.: Noninvasive evaluation of graft steatosis in living donor liver trans-plantation. Transplantation 2004; 78(10): 1501-1505.12) Iida T, Ogura Y, Oike F, et al.: Sur-gery-related morbidity in living do-nors for liver transplantation. Trans-plantation 2010; 89(10): 1276-1282.13) Kiuchi T, Kasahara M, Uryuhara K, et al.: Impact of graft size mismatching on graft prognosis in liver transplanta-tion from living donors. Transplanta-tion 1999; 67(2): 321-327.14) Kaido T, Mori a, Ogura Y, et al.: Low-er limit of the graft-to-recipient weight ratio can be safely reduced to 0.6% in adult-to-adult living donor liver trans-plantation in combination with portal pressure control. Transplant Proc 2011; 43(6): 2391-2393.15) Egawa H, Ueda Y, Ichida T, et al.: Risk factors for recurrence of primary scle-rosing cholangitis after living donor liver transplantation in Japanese reg-istry. Am J Transplant 2011; 11(3): 518-527.16) Ono Y, Kawachi S, Hayashida T, et al.: The influence of donor age on liver re-generation and hepatic progenitor cell populations. Surgery 2011; 150(2): 154-161.17) Tanabe M, Kawachi S, Obara H, et al.: Current progress in ABO-incompat-ible liver transplantation. Eur J Clin Invest 2010; 40(10): 943-949.

元のページ 

10秒後に元のページに移動します

※このページを正しく表示するにはFlashPlayer9以上が必要です